UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

The accuracy of clinical staging of stage I-IIIa non-small cell lung cancer: An analysis based on individual participant data

Navani, N; Fisher, D; Tierney, JF; Stephens, RJ; Burdett, S; NSCLC Meta-analysis Collaborative Group, .; (2019) The accuracy of clinical staging of stage I-IIIa non-small cell lung cancer: An analysis based on individual participant data. Chest , 155 (3) pp. 502-509. 10.1016/j.chest.2018.10.020. Green open access

[thumbnail of Joyce VoR 1-s2.0-S0012369218326072-main.pdf]
Preview
Text
Joyce VoR 1-s2.0-S0012369218326072-main.pdf

Download (359kB) | Preview

Abstract

BACKGROUND: Clinical staging of NSCLC helps determine prognosis and management of patients; few data exist on accuracy of clinical staging and the impact on treatment and survival of patients. We assessed whether participant or trial characteristics were associated with clinical staging accuracy as well as impact on survival. METHODS: We used individual participant data from RCTs, supplied for a meta-analysis of pre-operative chemotherapy (+/- radiotherapy) versus surgery alone (+/- radiotherapy) in NSCLC. We assessed agreement between clinical TNM (cTNM) stage at randomization and pathological TNM (pTNM) stage, for participants in the control group. RESULTS: Results are based on 698 patients who received surgery alone (+/- radiotherapy) with data for cTNM and pTNM stage. 46% of cases were cTNM stage I, 23% cTNM stage II and 31% cTNM stage IIIa. cTNM stage disagreed with pTNM stage in 48% of cases, with 34% clinically understaged and 14% clinically over-staged. Agreement was not associated with age (p=0.12), gender (p=0.62), histology (p=0.82), staging method (p=0.32) or year of randomisation (p=0.98). Poorer survival in understaged patients was explained by the underlying pTNM stage. Clinical staging failed to detect T4 disease in 10% of cases and misclassified nodal disease in 38%. CONCLUSIONS: This study demonstrates suboptimal agreement between clinical and pathological staging. Discrepancies between clinical and pathological T and N-staging could have led to different treatment decisions in 10% and 38% of cases respectively. There is therefore a need for further research into improving staging accuracy for patients with stage I-IIIa NSCLC.

Type: Article
Title: The accuracy of clinical staging of stage I-IIIa non-small cell lung cancer: An analysis based on individual participant data
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.chest.2018.10.020
Publisher version: https://doi.org/10.1016/j.chest.2018.10.020
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL
URI: https://discovery.ucl.ac.uk/id/eprint/10061396
Downloads since deposit
111Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item